[UV-A-1 therapy of subacute cutaneous lupus erythematosus].
Because of relative contraindications to corticosteroid or immunosuppressive treatment, a 71-year-old female patient with subacute cutaneous lupus erythematosus underwent serial whole-body irradiation with extremely long-wave ultraviolet light (UVA-1). The cumulative dosage was 186.1 J/cm2 within 9 weeks. Impressive improvement was achieved with some delay.
Sönnichsen
N
N
Dermatologische Klinik und Poliklinik, Humboldt-Universität zu Berlin.
Meffert
H
H
Kunzelmann
V
V
Audring
H
H
D000368:Aged; D001323:Autoantibodies / Q000032:analysis; D005260:Female; D006801:Humans; D008178:Lupus Erythematosus, Cutaneous / Q000276:immunology / Q000532:radiotherapy*; D011879:Radiotherapy Dosage; D014467:Ultraviolet Therapy / Q000379:methods*; D014916:Whole-Body Irradiation
D001323:Autoantibodies
UV-A-1-Therapie bei subakut-kutanem Lupus erythematodes.